Yahoo
ASX - Delayed Quote AUD

EZZ Life Science Holdings Limited (EZZ.AX)

0.3050 +0.0100 (+3.39%)
At close: 4:10:15 PM GMT+11
Chart Range Bar
Loading chart for EZZ.AX
  • Previous Close 0.2950
  • Open 0.3000
  • Bid 0.3050 x --
  • Ask 0.3200 x --
  • Day's Range 0.2900 - 0.3050
  • 52 Week Range 0.2900 - 2.6000
  • Volume 13,840
  • Avg. Volume 16,693
  • Market Cap (intraday) 14.356M
  • Beta (5Y Monthly) 1.15
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1100
  • Earnings Date --
  • Forward Dividend & Yield 0.04 (13.56%)
  • Ex-Dividend Date Nov 24, 2025
  • 1y Target Est --

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, South-East Asia, and internationally. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. The company was incorporated in 2015 and is based in Lidcombe, Australia.

ezzlife.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

EZZ.AX
78.37%
S&P/ASX 200 [XJO] (^AXJO)
1.98%

1-Year Return

EZZ.AX
86.21%
S&P/ASX 200 [XJO] (^AXJO)
0.83%

3-Year Return

EZZ.AX
45.19%
S&P/ASX 200 [XJO] (^AXJO)
27.35%

5-Year Return

EZZ.AX
32.41%
S&P/ASX 200 [XJO] (^AXJO)
19.64%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -11.50%

  • Return on Assets (ttm)

    -13.41%

  • Return on Equity (ttm)

    -20.25%

  • Revenue (ttm)

    46.28M

  • Net Income Avi to Common (ttm)

    -5.32M

  • Diluted EPS (ttm)

    -0.1100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.89M

  • Total Debt/Equity (mrq)

    1.95%

  • Levered Free Cash Flow (ttm)

    -7.56M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: